Company profile
Cardiff Lexington Corporation
OTC: CDIX · Healthcare · Medical - Care Facilities
#615 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
51DFH 48DQ 54GM 52SS 49
v0.1 · 65/100 weight · provisional
↑ disclosure history, operating margin · ↓ filing timeliness, return on equity
Methodology →Revenue TTM
$10.8M
Rev growth YoY (TTM)
+22.3%
Net income (FY)
-$5.5M
Employees
17
as of 2026-09-01
Market cap
$1.4M
as of 2026-09-01
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$11.5M$11.5M2025
Net income-$5.5M-$5.5M2025
Operating income$1.1M$1.1M2025
Total assets$29.1M$29.1M2025
Liabilities$26.0M$26.0M2025
Equity-$2.5M-$2.5M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Healthcare100%
By geography
Not disclosed.
The read
What is Cardiff Lexington Corporation’s revenue?
Cardiff Lexington Corporation booked $11.5M in FY2025 revenue, growing 39% year over year — faster than most Healthcare companies we track, at a -47.7% net margin.
Peers · Healthcare
Escalon Medical Corp.63CCYIOS Corporation49DBIMI International Medical Inc.——Jaguar Health, Inc.38DNEXGEL, Inc.51DJun An Kang Group Inc.——Neighbors
Broward →Key facts
CEOAlex Hunt Cunningham
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersFort Lauderdale, FL
ExchangeOTC: CDIX
Employees17
IPO date2005-12-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.